Maya Okafor, MD, Dipl. ABOM
Obesity Medicine & Endocrinology, Medical Reviewer
About
Dr. Maya Okafor is a diplomate of the American Board of Obesity Medicine and a medical reviewer for WomanRx, with additional training in endocrinology. Her focus is GLP-1 and incretin therapy, insulin resistance, thyroid disease, and metabolic health in women across the lifespan. For WomanRx she reviews weight-management, GLP-1, thyroid, and metabolic content against pivotal trials and Endocrine Society and Obesity Medicine Association guidance.
Credentials
- Obesity Medicine — American Board of Obesity Medicine
- Endocrinology, Diabetes & Metabolism
- Doctor of Medicine (MD)
Areas of expertise
- GLP-1 receptor agonists
- Compounded semaglutide and tirzepatide
- Insulin resistance
- Thyroid disorders
- Type 2 diabetes
- Metabolic health in women
Editorial methodology
Every article authored or reviewed by the WomanRx.com medical team is drafted from primary sources (peer-reviewed RCTs, FDA labels, society guidelines), reviewed against current clinical practice, and re-reviewed by a second board-certified clinician before publication. We update content within 30 days of any major guideline change. Conflicts of interest are disclosed on the methodology page.